Long
Glenmark Lifescience may be changing gears soon
Could be a triangle in formation....stop loss 404, final target of 560+ ..breakout max date by 13th of jan and max time to reach target 13th march 2023
Note
positives - CAPEX expansion on track, 240kl dahej expansion to come in from this quarter (but will take a few months for full utilization), strong ROCE, strong ROE, high dividend yield, low float...negatives - high dependence on related company Glenmark, pharma sector currently weak
opportunity - depressed valuations
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.